| | The agenda for the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference was specifically designed to provide you with all the information you need to stay up to date with the latest technologies and trends impacting the future of drug development.
One important focus will be on technology behind new advances aiming for better outcomes for the patient. That’s why both days of this conference include multiple concurrent sessions on this topic and the end-user experience. Through case studies, you will have the opportunity to find out how companies are leveraging innovation to develop new technologies and understand the science behind these breakthroughs.
| | |
|
| | Here are two sessions you can't miss:
| | |
|
| | | Challenges and Opportunities for Moving Treatments At-Home | | |
|
| | | Although moving from clinic to home administration has been a topic of discussion for some time, it was the pandemic that accelerated and changed drug formulation strategies. In this session, hear about various opportunities for making home drug delivery a reality and common practice!
Promise, Challenges, and Considerations for Developing Smart Injectables for Clinical and Commercial Operations
| Amin Sedighiamiri, PhD
Associate Director AstraZeneca |
Addressing Primary Container Challenges in Autoinjector Drug Delivery: Interim Results of a Multiphase Bioburden Study for a Cartridge-Based Autoinjector
| Amy Hartl, PhD
Director of Process Development
SHL Medical | | Lauren Guimond, MS
Analytical Sciences Manager
SHL Medical |
Moving Patient Training from Clinical to Home Settings
| | Tim McLeroy
Executive Director
Marketing & Patient Services
Noble International |
| | |
|
| | | From IV to SC: Innovative Approaches to “On-Body Delivery Systems” | | |
|
| | | Explore the move from the traditional intravenous to the subcutaneous injection, including the evolution of these new systems and how they can help transition drug delivery from hospital to home while meeting market demand.
Primary Container Sequence for On-Body Large Volume Injectors: From Vial to Pre-Filled Cartridge
| Tom Mayer, MBA
Business Unit Manager
Sonceboz SA |
| Mathias Romacker
Founder
Romacker Injection Devices Strategy LLC |
How Innovative Approaches to Subcutaneous Drug Delivery Can Shift the Point of Care from Hospital to Home: Building a Case for Oncology
| Jakob Lange, PhD
Senior Director Delivery Systems
Ypsomed AG |
Development of a Large Volume Delivery System with a Customized Injection Profile (Case Study)
| Pratik A. Mishra, MEng
Senior Systems Engineer
West Pharmaceutical Services, Inc. |
| Reut Atarot
Systems Engineering Manager
West Pharmaceutical Services, Inc. |
| | |
|
| | Additional concurrent sessions will discuss other emerging trends in this area, including, patient-driven collaborations and digital health solutions that empower the end user.
Other sessions will focus on how technology is impacting new product introduction and support of existing products, including approaches in manufacturing, sustainability of devices throughout the supply chain, and addressing challenges from lab to production.
Check out the agenda for more details on all the great content that will be shared.
Our conference is the place to be to explore the innovations driving the future of drug development, so make sure to save your seat and invite your colleagues! | | |
|
|
|
